Wegovy (semaglutide) injection pen

Wegovy is a brand name for semaglutide, a medication used for chronic weight management. The brand was developed by Novo Nordisk, a Danish multinational pharmaceutical company. The product shown is a demonstration pen used for education and training purposes, mimicking the actual subcutaneous injection delivery system used by patients.

Manufacturing for Wegovy occurs primarily in Denmark at Novo Nordisk's extensive production facilities, though the company utilizes a global supply chain with secondary assembly and packaging sites in countries such as France and the United States to meet massive international demand. As a flagship product of Novo Nordisk, the brand remains under the ultimate ownership of the Novo Nordisk Foundation through its holding company, Novo Holdings A/S, ensuring the brand's Danish heritage remains intact while operating as a global leader in diabetes and obesity care.